Peter Attia· MD
and this also the 500 of HCG three times a week it's not doing anything to boost endogenous production protection it's just protection
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and this also the 500 of HCG three times a week it's not doing anything to boost endogenous production protection it's just protection
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and now that was the median so there are patients who can have I don't want people to think hey if I do this is completely safe but it does help protect the decrease in catagenesis
so typically it depends on you're talking about younger patients though yeah so someone who's like in his 40s right so in his 40s I still try to the second so the category two is a young man who just wants to use HCG alone and that's not three thousand three times a week that's 1500 three times a week as a dose and then there's the last one and this is a study that we did at Baylor where there's a patient who wants to take tea and we give them HCG with it to protect the access and that's 500 three times so 500 1500 3000 there's three different patients